156 related articles for article (PubMed ID: 17505631)
1. [Diabetic nephropathy and cardiac disease].
Gross JL; Silveiro SP; Canani LH; Friedman R; Leitão CB; Azevedo MJ
Arq Bras Endocrinol Metabol; 2007 Mar; 51(2):244-56. PubMed ID: 17505631
[TBL] [Abstract][Full Text] [Related]
2. Prediction of cardiovascular events, diabetic nephropathy, and mortality by albumin concentration in a spot urine sample in patients with type 2 diabetes.
Viana LV; Gross JL; Camargo JL; Zelmanovitz T; da Costa Rocha EP; Azevedo MJ
J Diabetes Complications; 2012; 26(5):407-12. PubMed ID: 22677793
[TBL] [Abstract][Full Text] [Related]
3. [Microalbuminuria and diabetic nephropathy. Detection and correlation with other degenerative complications].
Thivolet C; Ayzac L; Simonet C; Rebattu B; Bernard P; Tourniaire J
Presse Med; 1990 Jun; 19(23):1075-80. PubMed ID: 2141408
[TBL] [Abstract][Full Text] [Related]
4. Diabetic nephropathy: diagnosis, prevention, and treatment.
Gross JL; de Azevedo MJ; Silveiro SP; Canani LH; Caramori ML; Zelmanovitz T
Diabetes Care; 2005 Jan; 28(1):164-76. PubMed ID: 15616252
[TBL] [Abstract][Full Text] [Related]
5. [Microalbuminuria. From diabetes to cardiovascular risk].
Monhart V
Vnitr Lek; 2011 Mar; 57(3):293-8. PubMed ID: 21495411
[TBL] [Abstract][Full Text] [Related]
6. Albuminuria--a marker of renal and generalized vascular disease in insulin-dependent diabetes mellitus.
Jensen T
Dan Med Bull; 1991 Apr; 38(2):134-44. PubMed ID: 2060321
[TBL] [Abstract][Full Text] [Related]
7. Albuminuria: a target for treatment of type 2 diabetic nephropathy.
de Zeeuw D
Semin Nephrol; 2007 Mar; 27(2):172-81. PubMed ID: 17418686
[TBL] [Abstract][Full Text] [Related]
8. Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease?
Chico A; Pérez A; Córdoba A; Arcelús R; Carreras G; de Leiva A; González-Sastre F; Blanco-Vaca F
Diabetologia; 1998 Jun; 41(6):684-93. PubMed ID: 9662051
[TBL] [Abstract][Full Text] [Related]
9. [Cardiovascular disorders and possibilities of their therapy in patients with type 2 diabetes mellitus and diabetic nephropathy].
Onuchin SG; Elsukova OS; Solov'ev OV; Onuchina EL
Klin Med (Mosk); 2010; 88(1):32-7. PubMed ID: 20369609
[TBL] [Abstract][Full Text] [Related]
10. [Microalbuminuria in diabetes mellitus--illness or symptom?].
Müller WA
Versicherungsmedizin; 1996 Jun; 48(3):70-6. PubMed ID: 8737541
[TBL] [Abstract][Full Text] [Related]
11. Microalbuminuria: is it a valid predictor of cardiovascular risk?
Tagle R; Acevedo M; Vidt DG
Cleve Clin J Med; 2003 Mar; 70(3):255-61. PubMed ID: 12678217
[TBL] [Abstract][Full Text] [Related]
12. Microalbuminuria: a common, independent cardiovascular risk factor, especially but not exclusively in type 2 diabetes.
Donnelly R; Yeung JM; Manning G
J Hypertens Suppl; 2003 Mar; 21(1):S7-12. PubMed ID: 12769161
[TBL] [Abstract][Full Text] [Related]
13. [Is microalbuminuria, an early marker of clinical nephropathy, also a cardiovascular risk factor?].
Raynaud E; Brun JF; Fédou C; Puech-Cathala AM; Pérez-Martin A; Orsetti A
Ann Biol Clin (Paris); 1998; 56(6):671-9. PubMed ID: 9853026
[TBL] [Abstract][Full Text] [Related]
14. High cardiovascular risk in patients with Type 2 diabetic nephropathy: the predictive role of albuminuria and glomerular filtration rate. The NID-2 Prospective Cohort Study.
Sasso FC; Chiodini P; Carbonara O; De Nicola L; Conte G; Salvatore T; Nasti R; Marfella R; Gallo C; Signoriello S; Torella R; Minutolo R;
Nephrol Dial Transplant; 2012 Jun; 27(6):2269-74. PubMed ID: 22090446
[TBL] [Abstract][Full Text] [Related]
15. Relationship between ABO blood groups and cardiovascular disease in type 1 diabetes according to diabetic nephropathy status.
Parente EB; Harjutsalo V; Lehto M; Forsblom C; Sandholm N; Groop PH;
Cardiovasc Diabetol; 2020 May; 19(1):68. PubMed ID: 32429911
[TBL] [Abstract][Full Text] [Related]
16. Is antihypertensive treatment the same for NIDDM and IDDM patients?
Parving HH
Diabetes Res Clin Pract; 1998 Apr; 39 Suppl():S43-7. PubMed ID: 9649959
[TBL] [Abstract][Full Text] [Related]
17. [How I evaluate...diabetic nephropathy. First part: micro- and macroalbuminuria].
Weekers L; Scheen AJ; Lefebvre PJ
Rev Med Liege; 1998 Aug; 53(8):494-8. PubMed ID: 9810212
[TBL] [Abstract][Full Text] [Related]
18. 'Microalbuminuria' and diabetes: a critique--assessment of urinary albumin excretion and its role in screening for diabetic nephropathy.
Bennett PH
Am J Kidney Dis; 1989 Jan; 13(1):29-34. PubMed ID: 2912062
[TBL] [Abstract][Full Text] [Related]
19. [Early detection by urinary proteome analysis : A new concept in patient management of diabetic nephropathy].
Beige J; Drube J; von der Leyen H; Pape L; Rupprecht H
Internist (Berl); 2020 Oct; 61(10):1094-1105. PubMed ID: 32897404
[TBL] [Abstract][Full Text] [Related]
20. Regression of albuminuria and its association with incident cardiovascular outcomes and mortality in type 1 diabetes: the FinnDiane Study.
Jansson FJ; Forsblom C; Harjutsalo V; Thorn LM; Wadén J; Elonen N; Ahola AJ; Saraheimo M; Groop PH;
Diabetologia; 2018 May; 61(5):1203-1211. PubMed ID: 29423580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
